Registry of Lobbyists
Version 4 of 4 (2008-01-02 to 2009-06-21) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Organization: |
British Columbia Pharmacy Association
#1530 1200 W. 73rd Ave Vancouver, BC V6P 6G5 Canada |
| Telephone number: | 604-269-2860 |
| Fax number: | 604-261-2097 |
| Responsible officer name and position during the period of this registration: | Marnie Mitchell, CEO |
| Description of the organization's activities: | Advocacy organization representing pharmacists and pharmacies in British Columbia |
| Organization's membership or classes of membership: | Pharmacists, pharmacies, students in UBC Faculty of Pharmaceutical Sciences |
| Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Marnie Mitchell |
| Position title: | CEO |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Health Canada (HC), Members of the House of Commons, Veterans Affairs Canada (VAC) | ||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
| Subject Matter: Areas of Concern: | Aboriginal Affairs, Health | ||||||
| Subject Matter: Retrospective: | Fees paid to B.C. pharmacies by federal drug plans; audits of such pharmacies; aboriginal health issues in general with emphasis on pharmaceutical servicesHealth Canada post-market surveillance of drugs | ||||||
| Subject Matter: Prospective: | Fees paid to B.C. pharmacies by federal drug plans; audits of such pharmacies; aboriginal health issues in general with emphasis on pharmaceutical servicesHealth Canada post-market surveillance of drugs | ||||||
Details Regarding the Identified Subject Matter
|
|||||||